| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10963476 | Vaccine | 2015 | 8 Pages |
Abstract
On average, RV5 appeared to be well tolerated among vaccine recipients, with no increase in nosocomial rotavirus transmission observed following NICU-based rotavirus vaccination. While the benefits of a RV5 NICU-based vaccination program for otherwise eligible preterm infants seem to outweigh the possible risk of vaccine virus transmission, further studies are needed.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Samuel Thrall, Margaret K. Doll, Charles Nhan, Milagros Gonzales, Thérèse Perreault, Philippe Lamer, Caroline Quach,